Thrombolysis and Iliofemoral Vein Stent Placement in Cancer Patients with Lower Extremity Swelling Attributed to Lymphedema

O’Sullivan, Gerard J.; Waldron, Dympna; Mannion, Edel; Keane, Maccon M.; Donnellan, Paul

doi:10.1016/j.jvir.2014.10.010

Cited by 20 publications

(16 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Until the introduction of endovascular venous stenting, long-term anticoagulation, compression therapy, balloon angioplasty, and bypass surgery were used to treat the patients. However, these were associated with potential complications and limitations (1,2). Invasive procedures, such as surgical bypass, in venous stenosis resulting from diffuse pelvic malignancies are limited, and the failure rate is relatively high [8,9].…”

Section: Discussionmentioning

confidence: 99%

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Zarrintan

Yavari

Tadayon

et al. 2021

Vasc Specialist Int

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Zarrintan

Yavari

Tadayon

et al. 2021

Vasc Specialist Int

View full text Add to dashboard Cite

show abstract

“…6,7 With the development of interventional radiology technology, the comprehensive use of percutaneous mechanical thrombectomy, CDT, angioplasty, and other methods under the protection of IVC filter can restore vascular patency immediately, improve symptoms, and provide a new treatment option for patients with venous stenosis and obstruction caused by malignant tumors. 8 The placement of a bare metal stent can quickly relieve the symptoms of obstruction and make subsequent treatment possible. However, this method cannot control tumor progression, especially in patients who have a longer survival period.…”

Section: Discussionmentioning

confidence: 99%

Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand

Yin

et al. 2020

Vasc Endovascular Surg

View full text Add to dashboard Cite

Objectives: To investigate the safety and efficacy of a stent combined with a linear strand of 125I seeds to treat malignant cancer–associated venous obstruction. Methods: We retrospectively analyzed the data of 57 patients with malignant cancer–associated venous obstruction. Nineteen patients underwent the placement of a stent combined with a linear strand of 125I seeds (group A), and 38 patients underwent the placement of a bare stent (group B). The following parameters were compared between the 2 groups of patients: symptom relief rate, duration of venous patency, survival time, quality of life, and adverse events. Results: A total of 34 stents and 527 seeds were implanted in group A, while a total of 57 stents were implanted in group B. The surgery success rate was 96.5%, and no serious complication related to the surgery was reported. Symptoms of venous obstruction improved significantly after surgery. The score of group A decreased from 14.74 ± 0.562 points before surgery to 2.79 ± 1.357 points after surgery( P < .001), and the score of group B decreased from 13.79 ± 1.398 points before surgery to 5.55 ± 3.674 points after surgery ( P < .001). The patency rate of group A was significantly higher than that of group B at 1 to 6 months after surgery (100%, 84.2%, 68.4%, 63.2%, 36.8%, 21.1% vs 68.4%, 23.7%, 18.4%, 7.9%, 5.3%, 2.6%, respectively; P < .05). Before treatment, there was no statistically significant difference in the Karnofsky Performance Status (KPS) score between the groups ( P = .791). After 1 to 6 months of treatment, the KPS score was significantly higher in group A than in group B ( P = .013). The median patency duration in groups A and B was 125 days (95% CI: 80.018-169.982) and 35 days (95% CI: 20.501-49.499), respectively ( P < .001). The median survival time of group A was 155 days (95% CI: 110.406-199.594), and that of group B was 98 days (95% CI: 55.712-140.288; P = .325). Multivariate analysis showed that the implantation of a stent combined with a linear strand of 125I seeds and the KPS score (≥80 points) were independent factors of long-term patency after stent placement. Conclusions: The placement of a stent combined with a linear strand of 125I seeds is a safe and effective treatment for venous obstruction caused by malignant tumors. This treatment provides prolonged patency compared with the placement of bare stent, and while it does not significantly improve the survival time of patients, it can improve their quality of life.

show abstract

“…CT scans obtained through oncology follow-up were used to assess the stent in patients with underlying malignancy. 8…”

Section: Post-operative Care and Follow-upmentioning

confidence: 99%

Factors Associated with Contralateral Deep Venous Thrombosis after Iliocaval Venous Stenting

Khairy

Neves

Hartung

et al. 2017

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

show abstract

Thrombolysis and Iliofemoral Vein Stent Placement in Cancer Patients with Lower Extremity Swelling Attributed to Lymphedema

Cited by 20 publications

References 32 publications

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand

Factors Associated with Contralateral Deep Venous Thrombosis after Iliocaval Venous Stenting

Contact Info

Product

Resources

About